These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4860569)

  • 1. The influence of carbon dioxide on the neuromuscular blocking properties of tubocurarine chloride and diallyl-nor-toxiferine dichloride (Alloferin Roche) in man. A comparative study.
    Coleman AJ; Ripley SH; Sliom CM; Knowles SL
    Bull Schweiz Akad Med Wiss; 1967 Aug; 23(1):98-105. PubMed ID: 4860569
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of diallyl-nor-toxiferine and d-tubocurarine in humans. Influence of the induction agent.
    Stovner J; Endresen R; Lund I
    Bull Schweiz Akad Med Wiss; 1967 Aug; 23(1):91-7. PubMed ID: 4860568
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diallyl-nor-toxiferin dichloride (Alloferin) non depolarizing muscle relaxant derived from calebash curare].
    Zaffiri O; Alessio-Vernì A; Mastroianni A
    Minerva Anestesiol; 1968 Dec; 34(12):1537-41. PubMed ID: 5743928
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative neuromuscular effects of Forane and halothane alone and in combination with d-tubocurarine in man.
    Miller RD; Eger EI; Way WL; Stevens WC; Dolan WM
    Anesthesiology; 1971 Jul; 35(1):38-42. PubMed ID: 4932621
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical experiences with diallyl-nor-toxiferine and the curare antidote galanthamine.
    Mayrhofer O
    South Med J; 1966 Nov; 59(11):1364-8. PubMed ID: 5333582
    [No Abstract]   [Full Text] [Related]  

  • 6. [Medicamentous muscle relaxation and hypocapnic muscle release].
    Kronschwitz H
    Z Prakt Anasth; 1970 Oct; 5(5):332-44. PubMed ID: 4330405
    [No Abstract]   [Full Text] [Related]  

  • 7. [2 years of exclusive use of diallyl-nor-toxiferine as relaxant in clinical anesthesia].
    Chott F
    Anaesthesist; 1966 Mar; 15(3):81-3. PubMed ID: 5987377
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative assessment of residual antidepolarizing block. II.
    Ali HH; Utting JE; Gray TC
    Br J Anaesth; 1971 May; 43(5):478-85. PubMed ID: 4254032
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of a subthreshold dose of d-tubocurarine on the neuromuscular blocking action of succinylcholine in anesthetized man.
    Schuh FT; Viguera MG; Terry RN
    Acta Anaesthesiol Scand; 1974; 18(2):71-8. PubMed ID: 4428934
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Sequential changes in tetanic tension fade after the administration of tubocurarine in man.
    Sugai N; Hughes R; Payne JP
    Br J Anaesth; 1973 Dec; 45(12):1233. PubMed ID: 4787022
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuromuscular blocking effects of tobramycin, gentamicin, and cefazolin.
    Lippmann M; Yang E; Au E; Lee C
    Anesth Analg; 1982 Sep; 61(9):767-70. PubMed ID: 7201757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THE INFLUENCE OF CARBON DIOXIDE ON THE NEUROMUSCULAR BLOCK CAUSED BY TUBOCURARINE CHLORIDE IN THE HUMAN SUBJECT.
    BARAKA A
    Br J Anaesth; 1964 May; 36():272-8. PubMed ID: 14168466
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of diallyl-nor-toxiferin in the group of relaxants].
    Ahnefeld FW; Halmágyi M
    Anaesthesist; 1966 Mar; 15(3):83-5. PubMed ID: 5987378
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative studies on various non-depolarizing muscle relaxants].
    Iizumi K
    Masui; 1972 Oct; 21(11):1111-20. PubMed ID: 4264742
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacology of alloferin (diallyl-bis-nor-toxiferine).
    Kajimoto N
    Acta Sch Med Univ Kioto; 1970 Mar; 40(3):291-304. PubMed ID: 5447691
    [No Abstract]   [Full Text] [Related]  

  • 16. [Relaxometry in the use of muscle relaxants].
    Kronschwitz H
    Bull Schweiz Akad Med Wiss; 1967 Aug; 23(1):69-79. PubMed ID: 6049586
    [No Abstract]   [Full Text] [Related]  

  • 17. [Our experience on the use of the new muscle relaxant diallyl-2-nortoxiferine, Alloferin].
    García Perla JL
    Rev Esp Anestesiol Reanim; 1971 Jan; 18(1):93-6. PubMed ID: 5552985
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical use of muscle relaxants.
    Foldes FF
    Bull Schweiz Akad Med Wiss; 1967 Aug; 23(1):5-24. PubMed ID: 6049585
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of the single twitch and tetanic response of rat tibialis anterior muscle during neuromuscular blockade by d-tubocurarine].
    Amaki Y; Kamide M; Kobayashi K
    Masui; 1982 Sep; 31(9):933-8. PubMed ID: 7154231
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of muscle relaxants using evoked electromyography. 2. Characteristic patterns of recovery curve with M-response during effective period of muscle relaxants].
    Suzuki H; Nakagawa H; Kanayama T; Yazaki S
    Masui; 1970 Dec; 19(13):1455-62. PubMed ID: 5531038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.